Lipid-based Nanoparticulate Drug Delivery

Title:Lipid-based Nanoparticulate Drug Delivery

Volume: 12

Author(s): Shivani Gandhi and Divyesh H. Shastri*

Affiliation:

• Department of Pharmaceutics, K.B. Institute of Pharmaceutical Education and Research, A Constituent College of Kadi Sarva Vishwavidyalaya, Gh-6 Sector-23, Kadi Campus, Gandhinagar, Gujarat, 382016, India

Abstract: The emergence of lipid-based nanoparticulate systems has significantly reshaped the landscape of drug delivery. This review encapsulates the advancements, challenges, and potential of lipid-based nanoparticulate drug delivery in modern therapeutics. Lipid-based nanoparticles, including liposomes, lipid nanoparticles, and solid lipid nanoparticles, harness the biocompatibility and biodegradability of lipids to encapsulate and deliver a diverse range of therapeutic agents. This platform offers solutions to various drug delivery challenges, such as enhancing drug solubility and bioavailability, achieving controlled and sustained release, targeted delivery, and co-delivery of multiple agents. These nanoparticles have demonstrated potential in overcoming biological barriers, including the blood-brain barrier, mucosal barriers, and cellular barriers, enabling the delivery of drugs to previously inaccessible sites. Biocompatibility and reduced toxicity are intrinsic attributes of lipid-based nanoparticles, minimizing immune responses and systemic toxicity while promoting personalized medicine possibilities. However, challenges in formulation, stability, and regulatory approval underscore the need for ongoing research and innovation in this field.

Cite this article as:

Gandhi Shivani and Shastri H. Divyesh*, Lipid-based Nanoparticulate Drug Delivery, Pharmaceutical Nanotechnology 2024; 12 () . https://dx.doi.org/10.2174/0122117385275514231127062730